Cite
APA Citation
Marton, C., Mercier-Letondal, P., Deschamps, M., Ferrand, C., Adotevi, O., Borg, C., Galaine, J., & Godet, Y. (n.d.). 40PInterest and potential of genetically engineered cord blood derived T cells for cancer immunotherapy. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095511213.0x00003a